Evidence map›Paper›PMID 42238643›Full record

ReviewReviews in cardiovascular medicine2026

The Role of Multimodality Imaging in Guiding Ventricular Tachycardia Ablation: An Updated Review.

Eiad Habib, Mahmoud Abdelnabi, Ramzi Ibrahim, Christopher Kanaan, Hoang Nhat Pham, Ahmad Alkhatib, Hesham Abdalla, Hunter VanDolah, Adam Bacon, Malak Tahsin and 4 more

Abstract readReview
In one paragraph

Review in Reviews in cardiovascular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Eiad HabibDepartment of Cardiovascular Medicine, Mayo Clinic, Phoenix, AZ 85259, USA.
Mahmoud AbdelnabiDepartment of Cardiovascular Medicine, Mayo Clinic, Phoenix, AZ 85259, USA.ORCID https://orcid.org/0000-0001-8016-9049
Ramzi IbrahimDepartment of Cardiovascular Medicine, Mayo Clinic, Phoenix, AZ 85259, USA.
Christopher KanaanDepartment of Cardiovascular Medicine, Mayo Clinic, Phoenix, AZ 85259, USA.
Hoang Nhat PhamDepartment of Medicine, University of Arizona, Tucson, AZ 85721, USA.
Ahmad AlkhatibDepartment of Internal Medicine, MedStar Health, Baltimore, MD 21044, USA.
Hesham AbdallaDepartment of Internal Medicine, Mayo Clinic, Phoenix, AZ 85259, USA.
Hunter VanDolahDepartment of Internal Medicine, Mayo Clinic, Phoenix, AZ 85259, USA.
Adam BaconDepartment of Internal Medicine, Mayo Clinic, Phoenix, AZ 85259, USA.
Malak TahsinDepartment of Internal Medicine, Creighton University, Phoenix, AZ 85013, USA.
Fares JamalDepartment of Hematology and Oncology, Mayo Clinic, Phoenix, AZ 85259, USA.
Abdulrhman EldeibDepartment of Internal Medicine, King Faisal Specialist Hospital and Research Center, 12713 Riyadh, Saudi Arabia.
Reza ArsanjaniDepartment of Cardiovascular Medicine, Mayo Clinic, Phoenix, AZ 85259, USA.
Hicham El MasryDepartment of Cardiovascular Medicine, Mayo Clinic, Phoenix, AZ 85259, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Multimodality imaging plays a pivotal role in ventricular tachycardia (VT) ablation by providing critical insights into arrhythmogenic substrates and guiding procedural strategies. This updated review explores the integration of various imaging techniques, including echocardiography, cardiac magnetic resonance (CMR), multidetector computed tomography (MDCT), electroanatomical mapping (EAM), and nuclear imaging, to optimize VT ablation outcomes. Echocardiography, particularly transthoracic echocardiography (TTE), is an essential first-line tool for evaluating structural heart disease and left ventricular function. Moreover, echocardiography aids in risk stratification and procedural planning by detecting regional wall motion abnormalities and thrombus formation. Meanwhile, intracardiac echocardiography (ICE) enhances ablation precision by providing real-time catheter visualization, improving procedural success, and reducing complications such as cardiac tamponade. Nonetheless, CMR is the gold standard for myocardial tissue characterization, enabling the identification of scar burden and conduction channels critical for VT pathogenesis. Late gadolinium enhancement (LGE) facilitates preprocedural planning by localizing arrhythmogenic substrates, predicting VT recurrence risk, and informing ablation strategies. Additionally, T1- and T2-mapping techniques refine the assessment of myocardial fibrosis and inflammation, further improving patient selection and outcomes. MDCT complements CMR by offering high-resolution anatomical visualization and aids in delineating scar distribution, epicardial fat, and vascular structures, informing safe and effective ablation approaches. The integration of these imaging modalities significantly enhances VT ablation precision, reduces recurrence rates, and improves patient outcomes.

Indexed as

cardiac magnetic resonancecatheter ablationelectroanatomical mappingintracardiac echocardiographylate gadolinium enhancementmultidetector computed tomographymultimodality imagingmyocardial scarpositron emission tomographyventricular tachycardia

Identifiers

PMID42238643
PMCPMC13227395

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.